Search research articles
Contact Us
Filters
Showing results (291-300 of 501) with videos related to
Page
of 51
Sort By:
Cancers
|
August 23, 2020
Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma Patients
Franz J Hilke, Tobias Sinnberg, Axel Gschwind, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 18, 2012
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline--Update 2012
Claus Garbe, Ketty Peris, Axel Hauschild, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 26, 2015
Five-year survival rates for treatment-naive patients with advanced melanoma who received ipilimumab plus dacarbazine in a phase III trial
Michele Maio, Jean-Jacques Grob, Steinar Aamdal, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 19, 2019
Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma
Sophia Kreft, Anja Gesierich, Thomas Eigentler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2013
Myeloid-derived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cells
Benjamin Weide, Alexander Martens, Henning Zelba, et al.
Nature Reviews. Disease Primers
|
May 19, 2016
Melanoma
Dirk Schadendorf, David E Fisher, Claus Garbe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 17, 2007
Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma
Christina Pfannenberg, Philip Aschoff, Sandra Schanz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 2, 2016
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016
Claus Garbe, Ketty Peris, Axel Hauschild, et al.
Molecular Cancer Research : MCR
|
May 11, 2018
YB-1 Expression and Phosphorylation Regulate Tumorigenicity and Invasiveness in Melanoma by Influencing EMT
Corinna Kosnopfel, Tobias Sinnberg, Birgit Sauer, et al.
Journal for Immunotherapy of Cancer
|
August 6, 2020
Is there a link between very early changes of primary and secondary lymphoid organs in <sup>18</sup>F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy?
Ferdinand Seith, Andrea Forschner, Benjamin Weide, et al.
Page
of 51
Search research articles
Search
Showing results (291-300 of 501) with videos related to
Sort By:
Page
of 51
Cancers
|
August 23, 2020
Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma Patients
Franz J Hilke, Tobias Sinnberg, Axel Gschwind, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 18, 2012
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline--Update 2012
Claus Garbe, Ketty Peris, Axel Hauschild, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 26, 2015
Five-year survival rates for treatment-naive patients with advanced melanoma who received ipilimumab plus dacarbazine in a phase III trial
Michele Maio, Jean-Jacques Grob, Steinar Aamdal, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 19, 2019
Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma
Sophia Kreft, Anja Gesierich, Thomas Eigentler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2013
Myeloid-derived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cells
Benjamin Weide, Alexander Martens, Henning Zelba, et al.
Nature Reviews. Disease Primers
|
May 19, 2016
Melanoma
Dirk Schadendorf, David E Fisher, Claus Garbe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 17, 2007
Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma
Christina Pfannenberg, Philip Aschoff, Sandra Schanz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 2, 2016
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016
Claus Garbe, Ketty Peris, Axel Hauschild, et al.
Molecular Cancer Research : MCR
|
May 11, 2018
YB-1 Expression and Phosphorylation Regulate Tumorigenicity and Invasiveness in Melanoma by Influencing EMT
Corinna Kosnopfel, Tobias Sinnberg, Birgit Sauer, et al.
Journal for Immunotherapy of Cancer
|
August 6, 2020
Is there a link between very early changes of primary and secondary lymphoid organs in <sup>18</sup>F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy?
Ferdinand Seith, Andrea Forschner, Benjamin Weide, et al.
Page
of 51